StemCell Therapy

What is your position on the Federal Governments move to subject Madagascars COVID Organic herbal cure to clinical tests for probable use in Nigeria?My position is not an advisory rather it is a complementary statement to the steps the Federal Government has taken about a week now. We can see that the government is making efforts by fostering collaboration between the Traditional Complementary and Alternative Medicine arm of the Ministry of Health and NAFDAC to call on traditional medicine professionals who have a cure for COVID-19 to submit it for testing. This is indeed a very good move that we must commend. But if this had come earlier, it would have been better as it would have helped in the nations fight against coronavirus.

However, I honestly think the government is yet to have sufficient believe in traditional medicine practitioners of this great nation who are learned and professionals in their practice. In point of fact, gone are the days where we can hardly find learned practitioners in this noble field of medicine. Unknown to many, natural medicine practices is changing very rapidly for good every single day; but the Federal Governments support will only make it better and safer.

It really embitters that we can embrace a solution from Madagascar even though we have everything it takes to develop and produce locally made herbs that will aid in the fight against COVID-19. Long before Covid Organics was produced, the call had gone far and wide, pleading with the Federal Government to recognise the traditional medicine in the fight against COVID-19. We are giants of Africa and we should be the ones leading in innovative and integrative ways of attending to problems like this.

You recently shared some content on your business social media pages asking the Federal Government to give you room to treat Coronavirus. Have you really developed a cure?To start with, it is important to recognise the fact that coronavirus is a global pandemic, which requires everyones support to overcome. Without doubt, the Nigerian authorities in charge of managing this virus have been doing well in identifying cases nationwide and working round the clock to combat the virus. But the fight against this pandemic may not be successful if we do not begin to look in the direction of integrative medicine. As a biochemist and natural medicine doctor leading a team of other natural medicine healthcare professionals, what good does it do if we do not add our meaningful and informed contribution to the fight against COVID-19? If given the opportunity, we have a lot to offer with integrative medicine approach as our indigenous herbs also have what it takes to combat this novel virus.

So what do you want government to do?We want to work with the Federal Government and we hope they allow us to work with them. Over the past years, we have been able to help well meaning Nigerians in the fight against some diseases such as HIV, hepatitis, cancer and asthma, among many others, through our different types of therapies. In fact, we as practitioners at Olaking International Holistic Medicine (OIHM) Company practice not less than 10 therapies, part of which includes herbal medicine, acupuncture, traditional Chinese medicine, cupping and Islamic medicine therapies, to mention just a few.

Our call is that the Nigerian government should give room for integrative medicine where we combine both existing treatment methods with natural medicine approaches and remedies. We believe this will go a long way to help in treating Nigerians of this pandemic.

What are the treatment remedies you have developed for COVID-19 patients?Firstly, it should be said that the practitioner who does not combine and employ all that is good in each and every system of diagnosis and treatment is not worthy of the confidence of the public. On that score, I practice or employ much therapies other than my herbal medicines so far they are good, as there is no branch of medicine that is self-sufficient to cure especially chronic or viral diseases. This is very important because some patients already have underlying health issues prior to contracting COVID-19 and of course the symptoms are distinct amongst them; some do not even have symptoms yet. It should be noted that my call is and has been an integrative system of medicine whereby natural medicine will be employed alongside the orthodox medicine. This I know would surely bring remarkably, outstanding recovery rate in patients with life-threatening diseases.

Has your approach or treatment been scientifically proven?My approach is not scientific but my remedies have been scientifically proven to be safe and non-toxic at optimum doses and dosages. There is a clear difference between treatment approach and treatment remedies. My approach is based on the fact that says, the body is self-curative or there is healing power within. Most people realise, however, that the body is self-curative where a cut or broken bone is concerned; but they fail to understand that this is also the case with diseases as a whole.

It is not possible to cure a virus with scientific approach because orthodox medicine is guided by cellular pathology and considers that endogenous and exogenous causes operate in the production of disease, the constitution of a patient has no significance and causation are considered supreme, primary and worthwhile. In orthodox medicine, all patients suffering from the same disease are treated alike with special regard to the complications. Whereas in natural medicine, every sick individual is different with regard to his constitution, cause of his sickness and peculiar character of his disease.

Have you treated anybody suffering from the pandemic successfully?HIV/AIDS is a global pandemic and had since been said to be incurable. I have cured HIV and HBV patients successfully with my multifaceted and broad-spectrum regimen and this is why I so much believe that I can cure COVID-19 if given the opportunity. My knowledge and understanding of natural medicine principles and philosophy has really helped me to successfully treat, manage or cure many diseases.

In natural medicine, we do not focus on the germ or virus but on the soil, which they thrive or multiply. Our major interest is to remove the filth, which is the breeding ground of germs. Nature cure does not deny the existence of germs but it does not admit the idea that germs are the cause of diseases. Germs do not begin the trouble; they appear and flourish only where there is accumulation of morbid and toxic materials.

Coronavirus is not special and is not difficult to deal with if only we can focus on the above philosophy and make sure we view the patients as individual entities. In light of this, if a patient has a disease prior to contracting coronavirus, we will take into consideration both the disease and the newly contracted coronavirus, otherwise the inherent forces within him will lose the fight because his vitality may be too low; his injury or morbid encumbrance may be too great; harmful or inadequate treatments may have been given.

What is the proof of the efficacy of your cure?For the efficacy of my remedy for COVID-19, I sincerely have no iota of doubt about it. My belief is that SARS-Cov-2 (cause of COVID-19) will only replicate when the soil in which it occupy is accumulated with toxins which then will result to lowered vitality, abnormal composition of blood and tissue damage.

As such, the fundamental cure of COVID-19 will only be achieved by increasing the vital energy within, raising the vitality (immune system), purifying the blood stream, removing the morbid matters from the body through the organs of elimination, and modulating local inflammation in the respiratory tissues hence recruiting specific antibodies against the virus. I have severally used this principle for many so called incurable viral diseases such as HIV, hepatitis, herpes, etc., and it has actually been successful.

My remedy is a mixture of more than 10 Nigerian herbs having Euphorbia unispina as one of the major active ingredients. Whats more, the remedy is anti-inflammatory, antiviral, antioxidant, antipyretic, expectorant, analgesic, depurative, antibiotic and detoxicant.

NAFDAC is saying nobody has applied for the testing of his/her drug. Does it mean you have not applied to the agency for clinical trials and certification of your remedy?Efforts have been made to no avail. Im hopeful my product will get to NAFDAC at the appropriate time so that necessary testing and clinical trials could be carried out on it.

Personally, Im ever ready tosubmit my solution, which is a combination of over 10 Nigerian herbs to the necessary agency for testing and approval. And I also want to encourage my fellow practitioners not to relent in their support to the Federal Government in all ways possible in this fight. It is not the fight of the government alone. It is a fight of the whole nation and we must do everything possible in our knowledge and practice to ensure that we save the lives of Nigerians and the wellbeing of the nation during this global trying times. We have what it takes to treat coronavirus patients with our homegrown herbs. More than ever, we need all the support we can get from the government so as to provide healthy solutions in the fight against COVID-19.

How can coronavirus be prevented naturally?In natural medicine, the major ways of preventing diseases, not just COVID-19, are by eating healthy foods, maintaining proper hygiene, exercising and taking natural supplements. All these are purposefully to increase the systems vitality and keep the immune system at optimal level in order to be able to fight against germs and diseases. Coronavirus had really made the world think more of prevention than cure and more of environmental and personal hygiene than finding cure.

Nature cure does not deny the existence of germs but it does not admit the idea that germs are the cause of diseases. Germs do not begin the trouble; they appear and flourish only where there is accumulation of morbid and toxic materials. This means that COVID-19 wouldnt have existed if the laws of nature are duly abided by and practiced with maximum honesty.

The most effective and natural way to prevent diseases is by consuming lots of cleansing and hormone-balancing foods. Avoid cooking fruits; strive to eat fruits on empty stomach and dont peel the skin off when you can eat it. Eat fruits separately to help digestion. Take cabbage raw, take fenugreek, oats, millet, mustard and peas. Take non-starchy vegetables such as green pepper, collards, cucumber, broccoli, cabbage and spinach. Take fish,beans, brown rice, walnuts, almonds and garlic (dont take if you suffer from low blood pressure). Drink enough water daily. Each morning, drink a glass of pure water with one squeezed organic lemon followed by two tablespoons of extra virgin olive oil. Incorporate alkaline forming foods into your diet such as vegetables, olive oil, lemons, limes, asparagus, onions, parsley, raw spinach, garlic, broccoli. Minimise acid forming foods in your diet such as milk, blackberries, cranberries, beef, pork, cheese, ice cream, cashews, white rice, corn, buckwheat, white sugar and artificial sweeteners.

Stress and negative thoughts can also cause an acid environment, avoid it. Consume at least 75 per cent raw foods. Cooking, frying or heating foods at high temperature destroys precious enzymes and this leads to accumulation of toxic waste the body cant get rid of and causes lots of health problems.

Read the original here:
'Coronavirus can be treated with homegrown herbs'Saturday Magazine - Guardian

On Thursday, three leading public health experts hosted a Zoom call to discuss the current state of the COVID-19 pandemic in Texas. As the understanding of the virus within the scientific community has grown, the advice of expertsand the models theyre using to forecast the future of the diseases impacthas evolved too. The conversation was hosted by the nonprofit scientific institution The Academy of Medicine, Engineering & Science of Texas (TAMEST), and featured Peter Hotez, dean of the National School of Tropical Medicine at the Baylor College of Medicine; Rebecca Fischer, assistant professor of epidemiology and biostatistics at Texas A&M; and Lauren Ancel Meyers, professor of integrative biology at the University of Texas at Austin. The three scientists shared their views on the state of the pandemic, and discussed the risks of Texass reopening.

Here are the key takeaways from what they had to say.

Unlike other regions, Texas seems to have instituted social distancing and lockdown measures before the disease began wide-scale community spread. In New York, Hotez said, community transmission likely began in early February, and continued spreading until the city instituted social distancing measures on March 22. In Texas, though, our public safety measures went into effect before significant spread. Hotez says that relatively early action likely slowed the outbreak of the disease greatly.

Now more than ever Texans are connecting over shared stories. Enjoy your unlimited access to our site. To have Texas Monthly magazine delivered to your home, becomeasubscriber today.

That few weeks of extra time made a huge difference, Hotez said. But it also raises a question: how do we ensure that we continue to reap the benefits we saw from the sacrifice of social distancing, even as the state begins reopening businesses and relaxing guidelines? Hotez, whose son works in the beleaguered oil and gas industry, argued that economic recovery and the slowing of the disease are strongly correlated, rather than at odds with each other. How do we build the public health infrastructure that we need to sustain that recovery? he said. My big worry is that things will move ahead for the next couple of weeks, but as we move into the summer and fall, our ICUs will fill up. Thatll have people very worried about returning to work, and well begin to lose ground.

Meyers, whose team at UT-Austin has created a forecasting model used by the New York Times and 538.com as part of their projections on the disease, cautioned that a second wave may be an inevitability, based on our current understanding of how the disease spreads. According to Meyers, the R0 figure, which indicates how many other people a COVID-positive individual is likely to infect, dropped to 0.8 in Austin during the height of social distancingbut as of mid-May, it had climbed to around R0 0.95. As long as that number is under 1, the disease will eventually stop spreading, and the lower the R0 value, the quicker the outbreak comes to an end. But absent a lockdown, that number will continue to grow.

Restaurants, retailers, and hair salons have reopened, while bars and other businesses may get the green light from Governor Greg Abbott on May 18. But according to Meyers, there are two likely scenarios for the future, based on what we understand right now of the spread of the disease. Both share one thing in common: a likely spike in hospitalizations in June. Where they diverge is in how authorities and the public in general respond.

In one scenario, there are no formal restrictions on which businesses are allowed to open, no enforcement of social distancing policies, and no additional action taken when a second wave begins. (The modelers assume that about half the population is still hesitant to resume normal activity regardless of formal rules.) In that situation, she said, hospitalizations would peak to unmanageable levels, even with a very optimistic estimate of their surge capacity, by mid-June. If that happens, the sort of death toll that places like New York and Italy experienced would come to Texas. That does not include excess deaths that werent from COVID, she said, estimating that the death toll would quickly reach into the thousands.

In the second scenario, restrictions are again fully lifted, but once hospitalizations begin to spike, officials take swift action. In that situation, We put our foot on the brake before that happens, said Meyers. She mentioned eighty new hospitalizations in a day in Austin as one possible trigger for a local lockdown, which could be lifted when new admissions fall below a certain level. Our projection under that policy is that in mid-June, wed see a new lockdown lasting three months, she said. Thats significantly longer than the one we experienced from mid-March to May 1. In this case, thered likely be a third wave later in the fallbut at that point, enough of the population would probably have been exposed, and presumably have at least short-term immunity, that an additional lockdown wouldnt be necessary.

We need to have really good situational awareness, she said. We are hard at work estimating how quickly the virus is spreading as policies change, so we can take steps to slow transmission before its too late. If you wait until things look threatening in your hospitals, its too late.

The University of Texas model, which focuses on Austin but which Meyers said largely applies to other cities around the state, isnt based on testing data that comes from the state. Rather, Meyers said, its based on unprecedented coordination with the city, local hospitals, and researchers to get an accurate count of hospital admissions every day.

Hotez asked the other scientists about the problems that stem from the states relatively modest amount of testing. How do you have a robust alert system without testing data to feed into it? he asked. Fischer said the paucity of testing means that researchers still dont have a clear idea of how widely the virus is spreading, or whats happening among groups who face barriers to seeking care or who are asymptomatic.

If there is a way to expand testing to make it accessible to everyone, thats our most valuable tool, Fischer said. Fever screening is not our most useful toolits too labor-intensive, without much benefit. So when we talk about, say, students coming back to live in dorms, how do we do that? I dont know the answer to that question.

One consequence of our current lack of testing capacity is that we dont know how many Texans have been infectedwhich means that we dont know how far along we are on the path toward herd immunity, where the disease stops spreading because most people are immune to it. Currently, the detected cases represent just .2 percent of the population in Texasand thats likely an undercount. Even if the actual number of infections is ten times the number of diagnosed cases, thats still not enough to bring us close to herd immunity, Fischer argued. Without a way to expand and liberally test people, including those without signs, its really hard to gauge this, she said. And scientists arent even certain that an infection confers some period of immunity.

We dont actually know if people are immunized after infection, Meyers said. But unfortunately, the models are consistent with influenza and other respiratory infectionsthat this spreads quickly and silently, so over 50 percent of the population will have to be infected before this thing starts to dissipate on its own. Its very likely that very few people have been infected so far, so theres no silver bullet until we get a vaccine.

One grim possibility Meyers noted is that in the event we do see our hospitals overwhelmed from an unchecked spread of the disease, those who survive could get to that point more quickly. If this gets out of hand and a single-wave pandemic runs its course, we might be on the other side of this in a very bad way in a short amount of time, she saidat the cost of many thousands of lives.

The impact of the disease in Texas has thus far fallen largely on the elderly, especially those who live in long-term care facilities. While the overall case fatality rate is around 3.8 percentthat is, 3.8 percent of people who receive a clinical diagnosis die in a hospital from COVID-19a staggering 43 percent of those deaths have occurred among nursing-home residents. Parts of the state that have seen clusters of COVID-19 in nursing homes have seen much higher fatality rates. In the seven-county Brazos Valley region, for instance, its at nearly 11 percent.

People 65 and older may really need to be sheltering in place for the foreseeable future, even if the rest of the population relaxes, Meyers said.

The conversation wasnt particularly optimistic, in terms of short-term hope that transmission of the disease (and subsequent hospitalizations and deaths) will stop without additional lockdown measures. But one piece of hope that did come up centered on the ability and ingenuity of Texans to build a safer, smarter way of doing things, and an economy that adapts to the reality of the situation.

Hotez spoke of harnessing the robust scientific and engineering horsepower of Texans to create systems that can manage the spread of the pandemic. Given the amount of skill and talent in Texas, it might be possible to put in place syndromic surveillance and contact-tracing measures faster than hospitalizations and deaths spread. Because those are lagging indicators, which means that the disease spreads for several weeks before the impact of those things is felt around the state, there is still time to put them in placeif we start before those things happen.

The short answer is we need to bring the great minds and engineers together to tackle this challenge, Meyers said.

But even if youre not about to develop a contact-tracing app or a system for investigators to track and notify everyone an infected person comes in contact with, she thinks there are ways we can all help slow the spread of the diseaseone that would involve individuals taking on the responsibility of staying at home, and notifying the people theyve come in contact with, as soon as they start experiencing symptoms, so those people can also avoid potentially infecting others. It could actually go a long way, she said, Given how under-equipped we are for testing, contact tracing, and isolation.

See the article here:
What Public Health Experts Are Saying About the Coronavirus in Texas Right Now - Texas Monthly

Deepak Chopra, Special to SFGate

By Deepak Chopra, MD and Gustaf Kranck, M.Sc.

There is widespread awareness of the wellness movement in this country, and the term self-care is being more and more recognized. Since advice has existed for decades on proper diet, exercise, sleep, and the avoidance of alcohol and tobacco, in what way is self-care an advance? This seems like a critical question during the COVID-19 pandemic.

Self-care is an advance over the usual well-known preventive measures if it can do more, in other words, if there are choices that improve the whole mind-body system. Increasingly the key to self-care seems to be the vagus nerve. The general public awaits a silver-bullet treatment and a future vaccine, but the benefits associated with the vagus nerve are accessible by anyone right now.

A bit of anatomy first: twelve major nerves radiate out from the brain, and these so-called cranial nerves connect the brain to every area of the body. They function like information superhighways, constantly sending messages back and forth from brain to body. The most important cranial nerve is called the vagus nerve, named from the Latin word for wandering. The vast majority of sensory signals to and from the heart, lungs, stomach, and intestinal tract travel along the six miles of the vagus nerve.

In the past few years, a surprising discovery was made: deep, regular breathing stimulates the vagus nerve, sending a signal of relaxation that is very effective in settling down the stress response. News stories about vagal breathing, as it was named, drew widespread attention. But as research became more focused, it emerged that the vagus nerve might be something like a master key in the body. In its wanderings the vagus nerve affects the heart, lungs, digestive tract, and the immune system. These are the critical systems involved when someone becomes infected with the COVID-19.

The implication is that by stimulating the vagus nerve, a holistic benefit might come to these systems altogether. One of the co-authors of this article, Gustaf Kranck, has a personal story connected with vagal stimulation. Among the many ways that the vagus nerve can be stimulated are meditation and yoga. After getting burned-out by stress after the 2008 great recession, Gustaf began to practice meditation and felt that it saved his brain. Motivated to explore further, he hit upon the wealth of research that is being conducted on the vagus nerve. At present there are thousands of scientific papers on the subject and vagus stimulation devices are FDA approved for depression. In recent months there has been published more than 150 papers on vagus nerve and Coronavirus most of them showing clear indications that the vagus nerve is central to the disease progress.

Here it is necessary to step cautiously. Recently an eminent French researcher, Dr. Jean-Pierre Changeux, published findings that indicated a kind of medical benefit from nicotine - which neurologically acts as a vagus stimulant. The findings from France were that those who were active smokers, even while contracting Coronavirus, seemed to have a more favourable disease progress than those who had recently stopped smoking. Needless to say , a controversy erupted. Promptly after the publication of these studies in late April, the French government ordered limitations on the sale of nicotine patches from pharmacies in order to prevent hoarding.

Yet it is completely non-controversial to state that activating the vagus nerve with meditation and yoga, along with deep regular breathing and good sleep, are known conclusively to improve functioning in the systems most affected by the virus, particularly the respiratory system. Just as thoroughly documented is meditations benefit in reducing the stress response, with implications for reducing inflammation, one of the key dangers when the bodys immune system overreacts to the virus.

Gustaf made another striking observation. When meditating and doing controlled breathing practice, he could measure how this vagus nerve activation brings heartbeat and breathing rhythms to perfect sync if he was in good health. His discovery was that with a hand-to-hand wearable electrocardiogram (EKG) he could simultaneously measure with high precision both the heart rate and breathing and therefore instantly test how well they were synchronized.

This synchronization is very important. There is a sound physiological reason behind this. The vagus nerve regulates oxygen delivery in the body, so that it is used most efficiently and without waste. You need more oxygen to muscles during exercise and to the gut when relaxed. Vagal nerve stimulation seems to be crucial here, and a test of breathing and heartbeat rhythms, which is non-invasive and quite simple, may be useful in determining who is well and who is sick (we are not claiming, however, that the sickness would specifically be COVID-19). In healthy people the breath and heartbeat are in sync; in sick people the two functions go out of sync.

We hope this information is useful in promoting self-care through the methods for vagus nerve stimulation already mentioned. It costs nothing to do vagal breathing, get a good nights sleep, meditate, and practice yoga. We feel this is the direction that self-care and the virus should take.

DEEPAK CHOPRA MD, FACP, founder of The Chopra Foundation, a non-profit entity for research on well-being and humanitarianism, and Chopra Global, a modern-day health company at the intersection of science and spirituality, is a world-renowned pioneer in integrative medicine and personal transformation. Chopra is a Clinical Professor of Family Medicine and Public Health at the University of California, San Diego and serves as a senior scientist with Gallup Organization. He is the author of over 89 books translated into over forty-three languages, including numerous New York Times bestsellers. His 90th book, Metahuman: Unleashing Your Infinite Potential, unlocks the secrets to moving beyond our present limitations to access a field of infinite possibilities. TIME magazine has described Dr. Chopra as one of the top 100 heroes and icons of the century.

Gustaf Kranck, founder of Vagus.co - a Cambridge (UK) producer of health monitoring wearables and vagus stimulation devices. He has a M.Sc. from Aalto University in Finland and in 2019 authored the study Vagal Tone Diagnostics with hand-to-hand ECG.

See original here:
Self-Care, the Vagus Nerve, and COVID-19 - SFGate

Text Size:A- A+

New Delhi: A group of researchers associated with Ministry of AYUSH, the Indian Council of Medical Research (ICMR) and the University Grants Commission (UGC) have questioned the usage of only modern medicines and the neglect of Ayurveda for treatment and prevention of Covid-19.

The researchers, in an article published in the Indian Journal of Medical Ethics, have called the neglect of Ayurveda an ethical issue.

The decision not to include evidence from the Indian AYUSH (Ayurveda, Yoga, Unani, Siddha and Homoeopathy) systems in the search for solutions and management of Covid-19 seems unreasonable and unfair, the researchers wrote in the paper titled Ayush, modern medicine and the Covid-19 pandemic.

The authors of the paper are Sarika Chaturvedi from DY Patil Vidyapeeth, Pune; Nandini Kumar, former deputy director general (senior grade), ICMR, and vice-president, Forum for Ethics Review Committees in India; Girish Tillu from Ayush Centre of Excellence; Sharad Deshpande, former professor and head of the Department of Philosophy, University of Pune; and Bhushan Patwardhan, vice-chairman of the UGC, who is also part of the Ayush Centre of Excellence.

Patwardhan and his team are researching whether Ashwagandha can be an alternate to hydroxychloroquine (HCQ)as a potential preventive medicine for Covid.

Also read: Can Dabur Chyawanprash or panchkosha meditation help with Covid? Unusual trials on in India

Currently, only modern medicine therapies are used on an empirical basis, however, the same principle is not considered for the use of AYUSH systems. Appropriate use of evidence is required, the paper states.

In the ethics context and in the interest of the larger public good, we suggest the inclusion of simple and safe measures from AYUSH systems in the integrative protocols for prophylaxis and treatment of Covid-19.

Pointing out that Ayurvedic therapies are known for their immunomodulation and rejuvenation properties, which are important in Covid-19 management, the paper says that a refusal to accept empirical evidence in support of the immunomodulatory potential of Ayurvedic rasayana and other AYUSH measures is neither in the peoples interest nor that of science, besides being unethical.

Several in vitro, animal and clinical studies have demonstrated the immunomodulatory effects of the rasayana drugs such as Ashwagandha (Withania somnifera), Guduchi (Tinospora cordifoloia), Amalaki (Emblica officinale) among many others, the paper adds.

Also read: Heard Charles took Ayurveda treatment: Minister seeks evidence-based AYUSH drugs for Covid-19

The paper also states that patients should be informed about all kinds of treatments available for the disease, including alternate Ayurvedic medicines, and that not giving a choice to patients is unethical.

The persons preference should be respected by providing all the relevant details about available evidence from the prevalent systems of medicine. Not informing patients of established and available alternatives is unethical, it says.

Currently in India, no hospital asks patients about their choice of therapy if they are Covid-positive. The protocol is to put patients on allopathic medicines.

The team of researchers says this is unfair, and has also questioned the exclusion of AYUSH in policy formulation.

The procedural conditions to guarantee fair decisions recommended in public health ethics include transparency, reasonable explanation and openness to revision, in addition to adherence to regulation. On this premise, the decision not to include evidence from the Indian AYUSH systems in the search for solutions and management of Covid-19 seems unreasonable and unfair, the paper argues.

While the paper raises questions, the Narendra Modi government has been trying to propagate the use of Ayurveda, with the PM himself, in one of his addresses to the nation, urging people to follow an AYUSH ministry advisory that suggested various measures to increase immunity.

Also read: After Modis appeal, AYUSH ministry gets over 2,000 proposals to tackle Covid-19 pandemic

ThePrint is now on Telegram. For the best reports & opinion on politics, governance and more, subscribe to ThePrint on Telegram.

Subscribe to our YouTube channel.

See the original post here:
Unethical, unreasonable to ignore Ayurveda for Covid treatment & prevention, say researchers - ThePrint

Lynn Dominguez in Recreation, Parks and Leisure Services Administration is used to going along on the guided nature hikes her students lead as part of their RPL 552 Environmental Interpretation course.

But the pandemic upended nearly everything Central Michigan University students and faculty are used to, and so her students ventured out alone into parks and backyards all over Michigan to fulfill their assignment with cellphone videos.

"I started noticing all the pine needles and moss all over the trails at the Ludington State Park, and I honestly didn't know much about the different things that are all over the forest floor," said Amber Sadler, a senior majoring in recreation and event management. "That's how the idea originated."

She created themes, goals and objectives; messaged classmates to compare ideas; and took to the trails to record her video.

Meanwhile, on the other side of the state, a few College of Medicine team members suited up in personal protective equipment to run medical scenarios at the simulation lab in Saginaw as students and residents watched and learned from home.

Finding remote learning solutions and successes became a new way of life for students and faculty this semester. Here are a few more examples.

School of Music faculty member Alicia Marie Valoti set out to involve her entire viola studio class in a musical video. She ended up also involving alumni from around the world.

"Each of the violists you see was a CMU student of mine in some way," Valoti said, "and each, including myself, recorded three different parts to be mixed together.

"The students come from Brazil, China, Ecuador and many different parts of Michigan, and in fact, in some of the videos, students recorded themselves in their home country."Graduate assistant Shawn Bouck edited and produced the video.

In the Department of Theatre and Dance, Heather Trommer-Beardslee's DAN 232 Dance Composition students also needed to find a way to perform together. The resulting assignment became a video, "Still Dancing Together," to which each dancer contributed a solo performance.

"Students used the choreography skills they had been working on in class to continue learning and creating together despite the physical distance," Trommer-Beardslee said. Class member Alynne Welch edited the video.

'Live from Home'

Meanwhile, integrative public relations students received real-life lessons in crisis management by watching videos CMU Police Chief Larry Klaus created as he and the department managed the impact of the pandemic on campus. Elina Erzikova's JRN 551 Case Studies in Public Relations class discussed the handling from a PR perspective.

Preschoolers plug in

CMU's Child Development and Learning Laboratory connected with its preschool students and their families through an online learning service called Storypark. Daily video sessions with songs, stories and movement activities kept the children engaged and their teachers and student teachers focused on learning, said Human Development and Family Studies faculty member Holly Hoffman.

MOVE doesn't stop

Community members with Parkinson's disease or multiple sclerosis rely on the CMU physical therapy program's popular MOVE for Health exercise class. Unable to host it in person, student leaders in the program created a YouTube video to keep participants moving.

Honoring an Honors tradition

CMU Honors Program students wait years to ring the gong in Powers Hall to celebrate completing their senior capstone research projects. The stay-home order only spurred their creativity. Students took to Facebook to "virtually" ring the gong using everything from wind chimes to a dinner bell to a metal bowl to the power of Photoshop.

Pipeline goes online

The nine-week Health Careers Pipeline program recruits a diverse group of ninth and 10 graders from area high schools who are interested in health professions careers. It was scheduled to begin the first week of Michigan's stay-home order, so organizers took it virtual with interactive games and videos and drew nearly 100% participation, said April Osburn, executive director of the Mid-Central Area Health Education Center.

Threads can't be broken

The annual student-run Threads Fashion show, scheduled for April, took on a new look after the pandemic canceled campus events. Instead of sending models to walk the runway, organizers called on alumni to post supportive videos on Facebook and continued to create social media posts with the event's look and theme.

"Threads Fashion show is continuing to promote the brand," said faculty advisor Ian R. Mull. Organizers also created a Threads Fashion show 2020 program, offered for sale, to spotlight the designers who would have been in the show.

Lessons from nonprofits

Even from home, the Nonprofit Leadership Student Alliance stuck to its 5 p.m. Thursday meetings. The academic registered student organization's members aim for careers leading nonprofit organizations. Turning their attention to the ways nonprofits are meeting needs during the pandemic, they produced a video to showcase what they've learned.

"The learning comes from students staying connected and committed," said Political Science and Public Administration faculty member Emma Powell, who works with the alliance. "I am so proud of this group I could probably write a book."

Shifting sales strategy

Marketing and Hospitality Services Administration faculty member Rebecca Dingus' MKT 340 Personal Selling course normally builds up to sales role-plays between Dingus and each of her students. This year, recognizing that not all students could meet virtually from home, she and a colleague from Marquette University recorded four versions of a sales call. Pairs of students critiqued them using the knowledge they'd gained from the course.

"They got to watch me sell four different ways," Dingus said. "It created a much richer learning experience than what I ever could have predicted." She plans to use the new assignment even when classes transition back to campus.

Sharing science stories

Anyone wanting to find successes in the College of Science and Engineering can look to the college's Facebook page.

"We've been highlighting faculty and students since the quarantine started," said Rob Wang, the college's communications coordinator. Among them:

Faculty members Jason Keeler and Jordan Watts teach with Maslow's Hierarchy of Needs in mind at this time, understanding that students need food, shelter, friendship and a sense of self-esteem before they can expect to succeed academically.

Junior mechanical engineering major Katya Dominguez shifted from a canceled study abroad program in South Korea to being able to quickly register for online classes and two independent studies.

Actuarial sciences and statistics sophomore Julie Colling shares strategies for keeping up with studies and taking time to reduce stress.

Forward into summer

With all campus events, camps and gatherings canceled through June 25 and the first session of CMU summer classes online only, remote connections will grow past the end of the spring semester.

The Speech-Language Specialty Clinic for area children is just one example of a vital program taking new form. About 40 virtual campers in the annual nine-week speech and language therapy program will connect through telepractice one to three times a week beginning May 26. Telepractice links the CMU student clinicians and the clinical instructors supervising them for assessment, intervention and consultation with children and their parents.

Another example is the Center for Excellence in STEM Education's summer camps, which will be held virtually as they begin in June. The free classes open for registration May 18. This year's camps will be smaller to allow for meaningful connections and will offer curbside pick-up for needed materials.

Originally posted here:
In a changed reality, finding new paths to success - The Morning Sun

Dominion-Post

Promisia Integrative says the extract in Arthrem should not be classed as prescription only. (File photo)

The makers of Arthrem, which has been sold as joint mobility supplement, have failed to stop it being made a prescription-only medicine, pending a legal review of the change.

The Minister of Health intends publishing a formal legal notice that the plant extract artemisia annua is a prescription-only medicine.

The extract is an ingredient of Arthrem, which Promisia Integrative has been selling for about six years as a dietary supplement in pharmacies and online without a prescription, the Court of Appeal said in a decision issued on Friday.

Promisia Integrative, a listed company based in Wellington, asked the High Court to review the decision to make the extract prescription only, and in the meantime it wanted to stop the change in its status.

READ MORE:* Joint supplement Arthrem's makers being prosecuted by Health Ministry* Arthritis remedy maker Promisia's survival is hanging on a lifeline

But the High Court refused that request and on Friday the Court of Appeal declined to hear an appeal against the decision.

Promisia is challenging the process used to come to the prescription-only decision, and in particular the data used to reach the decision that the extract might cause liver damage.

It said there were no compelling public safety reasons for the decision to take effect now rather than waiting until the court case has been decided.

Arthrem remained on sale in the meantime, but Promisia has told shareholders that it is exiting the natural products market and the decision to reclassify the extract would have minimal impact on the company.

supplied

Herb artemisia annua grown in Tanzania for Promisia Integrative to use in Arthrem. (File photo)

The Court of appeal decision records the company said sales dropped 90 per cent when the Director-General of Health published an alert, it may lose $1.3 million if it can't process the extract and has to compensate pharmacies for the stock they hold, and it has suggested losses of up to $50m.

The Court of Appeal said the potential financial losses were not discounted, but did not outweigh a public health risk that could not be discounted either.

The extract has been used in Chinese medicine for centuries and is sold as an aid to joint health and mobility, the High Court judge said. Central to the case is whether the extract is a food or a medicine.

See more here:
Makers of Arthrem fail to stop it being made 'prescription only' in court - Stuff.co.nz

Stem Cells Market research report provides an actual industry viewpoint, future trends and dynamics for market growth rate, market size, trading and key players of the industry with forecast period of 2026. This comprehensive research report is titled Stem Cells Market with Industry Analysis and Opportunity Assessment and it comprises a whole market scenario along with the dynamics affecting it.

Inquire for Sample Copy of this Report : https://www.marketinsightsreports.com/reports/05152017541/global-stem-cells-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread/inquiry?heraldwriteup

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Stem Cells Market: Apceth GmbH?Company KGNeostem Oncology, LlcMesoblastBiotime, Inc.Ocata Therapeutics, Inc.Pharmicell Co., Ltd.Gamida Cell Ltd.U.S. Stem Cell, Inc. (Bioheart)Cell Cure Neurosciences Ltd.Stemcells, Inc.Medipost Co., Ltd.Pluristem Therapeutics Inc.Reneuron Group PlcNeuralstem, Inc.Stempeutics Research Pvt. Ltd.Orthocyte CorporationAnterogen Co., Ltd.

and others.

Global Stem Cells Market Split by Product Type and Applications:

This report segments the global Stem Cells market on the basis ofTypesare:Adult Stem CellHuman Embryonic Stem CellInduced Pluripotent Stem CellRat Neural Stem CellOther

On the basis of Application, the Global Stem Cells market is segmented into:Drug Discovery and DevelopmentStem Cells Regenerative Medicine

Regional Analysis For Stem Cells Market:

North America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, Colombia etc.)Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Browse the report description and TOC:

https://www.marketinsightsreports.com/reports/05152017541/global-stem-cells-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread?heraldwriteup

Influence of the Stem Cells Market Report:

-Comprehensive assessment of all opportunities and risk in the Stem Cells market.-Detailed study of business strategies for growth of the Stem Cells market-leading players.-Conclusive study about the growth plot of Stem Cells market for forthcoming years.-In-depth understanding of Stem Cells market-particular drivers, constraints and major micro markets.-Favourable impression inside vital technological and market latest trends striking the Stem Cells market.

Get Flat 20% Discount at: https://www.marketinsightsreports.com/reports/05152017541/global-stem-cells-market-report-2020-by-key-players-types-applications-countries-market-size-forecast-to-2026-based-on-2020-covid-19-worldwide-spread/discount?heraldwriteup

Key Strategic Developments: The study also includes the key strategic developments of the market, comprising, new product launch, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilisation rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

Analytical Tools: The Global Stem Cells Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porters five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyse the growth of the key players operating in the market.

Customisation of the Report: This report can be customised as per your needs for additional data up to 3 companies or countries or 40 analyst hours.

Please connect with our sales team ([emailprotected] ).

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc.MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:

Irfan Tamboli (Head of Sales) Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687

[emailprotected] | [emailprotected]

This document has been composed with the free online HTML converter. Click here to give it a try.

https://www.linkedin.com/company/13411016/https://twitter.com/MIRresearch

More here:
Stem Cells Market Market Developments and Analysis (impact of Covid-19) 2020-2026 - Herald Writeup

A market study title Global Stem Cell Drugs Market Growth 2020-2025 added to the storehouse of MarketandResearch.biz offers an examination on the market which involves present execution of the overall global Stem Cell Drugs industry. The report studies expectations on the future status of the market based on this investigation. It contains complete coverage, intensive analysis, and actionable market insights to spot opportunities in existing and potential markets. A top to bottom diagram of product specification, innovation, product type and production analysis considering major factors, such as revenue, cost, gross and gross margin are given in the report.

Market Overview:

The research report thoroughly studies the overall market covering market size, growth scenario, potential opportunities, operation landscape, trend analysis, and competitive analysis of the global Stem Cell Drugs market. This study will help you achieve information or key data about the market, emerging trends, product usage, motivating factors for customers, competitor strategies, brand positioning, customer preferences, and customer behaviour. Authors of this report have provided in-depth information on leading growth drivers, restraints, challenges, growth factors, shortcomings, threats, trends, and opportunities.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketandresearch.biz/sample-request/128290

Competitive Environment And Market Fragmentation:

The report focuses on competitors commanding the sector and outlining the company profile. The analysis relies on SWOT analysis to reveal the competitive environment of the market throughout the world. Additionally, the report includes analysis of current development, market shares, syndicates and grade of investments with other chief companies, financial agreements affecting the global Stem Cell Drugs market.

Some are the key players taken under coverage for this study are: JCR Pharmaceuticals Co., Ltd, CORESTEM, Inc, Anterogen, Chiesi Pharmaceuticals, Pharmicell Co., Ltd, MEDIPOST, Takeda, New York Blood Center,

By regions, this report splits the global Stem Cell Drugs market into several key regions, with sales, revenue, price, and gross margin market share of top players in these regions, from 2015 to 2025 (forecast), like:Americas (United States, Canada, Mexico, Brazil), APAC (China, Japan, Korea, Southeast Asia, India, Australia), Europe (Germany, France, UK, Italy, Russia), Middle East & Africa (Egypt, South Africa, Israel, Turkey, GCC Countries)

In-depth analysis of global market segments by types: Cord Blood-Derived, Adipose-Derived, Bone Marrow-Derived, Others,

In-depth analysis of global market segments by applications: Acute Graft-versus-Host Disease, Crohns Disease, Amyotrophic Lateral Sclerosis, Osteoarthritis, Others

Key Benefits of Purchasing This Report:

The study provides an in-depth analysis of the global Stem Cell Drugs market with current and future trends. Current and future trends are outlined to determine the overall attractiveness of profitable trends to gain a stronger foothold in the market. Drivers and opportunities are evaluated to highlight the top factors responsible for market growth. Value chain analysis in the report gives a clear understating of the roles of stakeholders involved in the value chain.

ACCESS FULL REPORT: https://www.marketandresearch.biz/report/128290/global-stem-cell-drugs-market-growth-2020-2025

The Main Points Which Are Answered And Covered In This Report Are:

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketandresearch.biz

Read the original:
Global Stem Cell Drugs Market 2020 Analysis, Types, Applications, Forecast and COVID-19 Impact Analysis 2025 - Cole of Duty

The ' Chronic Myeloid Leukemia (CML) Treatment market' research report is latest addition by Market Study Report, LLC, that elucidates relevant market and competitive insights as well as regional and consumer information. In a nutshell, the research study covers every pivotal aspect of this business sphere that influences the existing trends, profitability position, market share, market size, regional valuation, and business expansion plans of key players in the Chronic Myeloid Leukemia (CML) Treatment market.

The research report on Chronic Myeloid Leukemia (CML) Treatment market is a comprehensive analysis of this business space and entails all the key aspects of the industry including net revenue estimates, present renumeration, periodic deliverables, segmental share, market size, and market trends.

Request a sample Report of Chronic Myeloid Leukemia (CML) Treatment Market at:https://www.marketstudyreport.com/request-a-sample/2414857?utm_source=algosonline&utm_medium=ADS

A brief assessment of the behavior pattern of the Chronic Myeloid Leukemia (CML) Treatment market over the forecast timeline has been cited in the report. Critical parameters such as growth drivers as well the expected growth rate followed during the study period are also documented in the report. It further elaborates on the potential growth aspects and restraints of this industry.

Main highlights of Chronic Myeloid Leukemia (CML) Treatment market report:

Geographical scrutiny of the Chronic Myeloid Leukemia (CML) Treatment market:

Chronic Myeloid Leukemia (CML) Treatment Market Segmentation:

Key insights presented in the report with respect to the regional outlook:

A thorough analysis of Chronic Myeloid Leukemia (CML) Treatment market with respect to the product landscape and application spectrum:

Product landscape:

Product types: Targeted Therapy, Chemotherapy, Radiation Therapy, Splenectomy and Stem Cell Transplant

Ask for Discount on Chronic Myeloid Leukemia (CML) Treatment Market Report at:https://www.marketstudyreport.com/check-for-discount/2414857?utm_source=algosonline&utm_medium=ADS

Main insights presented in the report:

Application landscape: IIII

Major discoveries of the report:

Other takeaways of Chronic Myeloid Leukemia (CML) Treatment market report:

Additional insight on the competitive outlook of the Chronic Myeloid Leukemia (CML) Treatment market:

Vendor base of the industry: Novartis AG, Stragen Pharma SA, Bristol-Myers Squibb, ARIAD Pharmaceuticals, Inc., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Incyte Corporation, Hospira, Inc., Bio-Path Holdings, Prism Pharmaceuticals, Otsuka Pharmaceutical Co. and Ltd

Vital parameters which define the competitive landscape of the Chronic Myeloid Leukemia (CML) Treatment market:

For More Details On this Report: https://www.marketstudyreport.com/reports/global-chronic-myeloid-leukemia-cml-treatment-market-growth-status-and-outlook-2019-2024

Some of the Major Highlights of TOC covers:

Executive Summary

Manufacturing Cost Structure Analysis

Development and Manufacturing Plants Analysis of Chronic Myeloid Leukemia (CML) Treatment

Key Figures of Major Manufacturers

Related Reports:

2. Global Mupirocin Calcium 2% Cream Market Growth 2020-2025Mupirocin Calcium 2% Cream Market report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Mupirocin Calcium 2% Cream by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.Read More: https://www.marketstudyreport.com/reports/global-mupirocin-calcium-2-cream-market-growth-2020-2025

Read More Reports On: https://www.marketwatch.com/press-release/africa-advanced-wound-care-market-share-future-scope-demands-and-projected-industry-growth-to-2024-2020-02-26

Read More Reports On: https://www.marketwatch.com/press-release/at-60-cagr-dental-implant-market-size-research-growth-forecast-to-surpass-usd-54695-million-by-2025-2020-02-27

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

Read more:
Trends of Chronic Myeloid Leukemia (CML) Treatment Market Reviewed for 2019 with Industry Outlook to 2024 - AlgosOnline

Global Precision Medicine market report provides an in-depth overview of Product Specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and Gross Margin. The company profiles of all the key players and brands that are dominating the Precision Medicine market with moves like product launches, joint ventures, merges and accusations which in turn is affecting the sales, import, export, revenue and CAGR values are mentioned in the report. The report is generated based on the market type, size of the organization, availability on-premises and the end-users organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa.

Global Precision Medicine Marketto grow with a substantial CAGR in the forecast period of 2019-2026. Growing prevalence of cancer worldwide and accelerating demand of novel therapies to prevent of cancer related disorders are the key factors for lucrative growth of market

Key Market Players:

Few of the major competitors currently working in the global precision medicine market are Neon Therapeutics, Moderna, Inc, Merck & Co., Inc, Bayer AG, PERSONALIS INC, GENOCEA BIOSCIENCES, INC., F. Hoffmann-La Roche Ltd, CureVac AG, CELLDEX THERAPEUTICS, BIONTECH SE, Advaxis, Inc, GlaxoSmithKline plc, Bioven International Sdn Bhd, Agenus Inc., Immatics Biotechnologies GmbH, Immunovative Therapies, Bristol-Myers Squibb Company, Gritstone Oncology, NantKwest, Inc among others.

Download Free PDF Sample Copy ofReport@http://databridgemarketresearch.com/request-a-sample/?dbmr=global-precision-medicine-market

Global Precision Medicine MarketBy Application (Diagnostics, Therapeutics and Others), Technologies (Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics and Others), Indication (Oncology, Central Nervous System (CNS) Disorders, Immunology Disorders, Respiratory Disorders, Others), Drugs (Alectinib, Osimertinib, Mepolizumab,Aripiprazole lauroxil and Others), Route of Administration (Oral,Injectable), End- Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) Industry Trends and Forecast to 2026

Competitive Analysis:

The precision medicine market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of mass spectrometry market for global, Europe, North America, Asia Pacific and South America.

Market Drivers

Market Restraints

Talk to The Author of Report @http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-precision-medicine-market

Market Definition:

Precision medicines is also known as personalized medicines is an innovative approach to the patient care for disease treatment, diagnosis and prevention base on the persons individual genes. It allows doctors or physicians to select treatment option based on the patients genetic understanding of their disease.

According to the data published in PerMedCoalition, it was estimated that the USFDA has approved 25 novels personalized medicines in the year of 2018. These growing approvals annually by the regulatory authorities and rise in oncology and CNS disorders worldwide are the key factors for market growth.

Grab Your Report at an Impressive 30% Discount! Please clickHere@https://www.databridgemarketresearch.com/request-a-discount/global-precision-medicine-market

Key Developments in the Market:

Competitive Analysis:

Global precision medicine market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global precision medicine market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Market Segmentation:

By technology:-big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others.

By application:- oncology, hematology, infectious diseases, cardiology, neurology, endocrinology, pulmonary diseases, ophthalmology, metabolic diseases, pharmagenomics, and others.

On the basis of end-users:- pharmaceuticals, biotechnology, diagnostic companies, laboratories, and healthcare it specialist.

On the basis of geography:- North America & South America, Europe, Asia-Pacific, and Middle East & Africa. U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

In 2017, North America is expected to dominate the market.

About Data Bridge Market Research:

Data Bridge Market Researchset forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:Corporatesales@databridgemarketresearch.com

Excerpt from:
Precision Medicine Market 2019: Industry Analysis and Detailed Profiles of Top Industry Players are Neon Therapeutics, Moderna, Inc, Merck & Co.,...

Recent Trends In Mucopolysaccharidosis Treatment Market 2020: Scenario Highlighting Major Drivers, Explores New Growth Opportunities, Developments and Future Forecasts To 2029

The innovative research report provides details on current and future growth trends as well as information on regions across the geographical landscape of the Mucopolysaccharidosis Treatment market. Future scope analysis of Mucopolysaccharidosis Treatment Market with systematic evaluation of the competitors offers a clear idea of the most fundamental challenges in the current market and the coming years. This top research report highlights the leading growth drivers, restraints, challenges, trends, and opportunities. This Report covers the Major players data, including- competitive situation, sales, revenue, and global market share of top manufacturers. Leading Companies are ArmaGen Inc., Others, BioMarin Pharmaceutical Inc., a Sanofi Company, Genzyme, Sangamo Therapeutics and Hamilton Storage Technologies.

Get Research Insights at (Use official eMail ID to Get Higher Priority): https://market.us/report/mucopolysaccharidosis-treatment-market/request-sample/

[Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction To The Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also Included]

The report aims to Outline and forecast, Top Vendors, industry research and end-user analysis and also provide to the reader a professional and in-depth industry analysis no matter you are the industry insider potential entrant or investor. A brief study of the industry with regards to market size concerning remuneration and volume aspects along with the current Mucopolysaccharidosis Treatment market shares scenario is offered in the research report. The report is all around made by considering its necessary information in the comprehensive global Mucopolysaccharidosis Treatment market.

In a detailed analysis of growth opportunities, investment feasibility, challenges, and obstacles to market development are covered in this report.Detailed research on market size, the share of leading industry players.Forecast information related to the Mucopolysaccharidosis Treatment market size and growth, consumer base and emerging market segments are elaborated in-depth in this Mucopolysaccharidosis Treatment report.Region-wise Mucopolysaccharidosis Treatment analysis will cover all the key factors related to revenue and Mucopolysaccharidosis Treatment market share of the leading industry players.An in-depth study of business profiles of the top Mucopolysaccharidosis Treatment players along with their revenue, consumer volume will help in planning business strategies.Marketing strategies, emerging trends in the industry, and comprehensive analysis of Mucopolysaccharidosis Treatment will lead to market development.Analysis of the major competitors in the market: BioMarin Pharmaceutical Inc.Genzymea Sanofi CompanyArmaGen Inc.Sangamo TherapeuticsOthersHamilton Storage TechnologiesProduct Type Coverage:Enzyme Replacement TherapyStem Cell TherapyOthersApplication Coverage: HospitalsClinicsSpecialty Care UnitOthersFollowing regions and Sub-regions are covered in this reportSouth America Mucopolysaccharidosis Treatment Market Covers Colombia, Brazil and ArgentinaNorth America Mucopolysaccharidosis Treatment Market Covers Canada, Mexico and United StatesEurope Mucopolysaccharidosis Treatment Market Covers Russia, Germany, Italy, UK and FranceThe Middle East and Africa Mucopolysaccharidosis Treatment Market Covers South Africa, UAE, Saudi Arabia, Nigeria and EgyptAsia Pacific Mucopolysaccharidosis Treatment Market Covers China, India, Southeast Asia, Japan and KoreaRead more details of the report at: https://market.us/report/mucopolysaccharidosis-treatment-market/#inquiry

[Note: Use Corporate eMail ID and Business Details to Get Higher Priority]

In-Depth Insight Of Mucopolysaccharidosis Treatment Market :Future Growth Of Mucopolysaccharidosis Treatment market By New Business Developments, Innovations, And Top Companies Forecast To 2029Determine Key Opportunities in the market sales scenario by analyzing trends in authorizing and co-development deals.The trend of Mucopolysaccharidosis Treatment market in the global industry with Market Development, Analysis, and Overview 2020-2029.Study the market in terms of generic and premium product revenue.Assessment of the global industry trends, historical data from 2012 to 2017, projections for the coming years, and anticipation of compound annual growth rates (CAGRs) by the end of the forecast period.Wide-ranging company profiles of leading participants in the industry.The composition of the market, in terms of dynamic molecule types and targets, underlining the major industry resources and players.Discoveries of new market prospects and targeted marketing methodologies for Global Mucopolysaccharidosis Treatment Market.Click Here to Buy Mucopolysaccharidosis Treatment Market Report: https://market.us/request-covid-19/?report_id=30107

Mucopolysaccharidosis Treatment Market IntroductionDefinitionTaxonomyResearch Scope

Executive SummaryKey Findings by Major SegmentsTop strategies by Major Players

Global Mucopolysaccharidosis Treatment Market OverviewMucopolysaccharidosis Treatment Market DynamicsDriversOpportunitiesRestraintsChallenges

PESTLE AnalysisOpportunity Map AnalysisPORTERS Five Forces AnalysisMarket Competition Scenario AnalysisProduct Life Cycle AnalysisOpportunity OrbitsManufacturer Intensity Map

Global Mucopolysaccharidosis Treatment Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by TypeGlobal Mucopolysaccharidosis Treatment Market Analysis by Type: IntroductionGlobal Mucopolysaccharidosis Treatment Market Size and Forecast by Region

Global Mucopolysaccharidosis Treatment Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by ApplicationGlobal Mucopolysaccharidosis Treatment Market Analysis by Application: IntroductionGlobal Mucopolysaccharidosis Treatment Market Size and Forecast by Region

Global Mucopolysaccharidosis Treatment Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by RegionGlobal Mucopolysaccharidosis Treatment Market Competitive Landscape, Market Share Analysis, and Company ProfilesMarket Share AnalysisCompany ProfilesCompany OverviewFinancial HighlightsProduct PortfolioSWOT AnalysisKey Strategies and DevelopmentsAssumptions and AcronymsResearch MethodologyContact

View Mucopolysaccharidosis Treatment Market Report TOC In detail: https://market.us/report/mucopolysaccharidosis-treatment-market/#toc

Contact Us:

Mr. Benni JohnsonMarket.us (Powered By Prudour Pvt. Ltd.)Tel: +1 718 618 4351.Email: [emailprotected]

Refer our Trending Reports:

Drilling Fluid Additives Market | 2020 Report with Manufacturers, Dealers, Consumers, Revenue, Regions, Types, Application 2029https://apnews.com/Wired%20Release/0630abc460566dcebbb6a008b62c957f

Trending News For Marine Power Market Rising Business Opportunities With Prominent Investment Ratio By 2029https://www.marketwatch.com/press-release/trending-news-for-marine-power-market-rising-business-opportunities-with-prominent-investment-ratio-by-2029-2020-02-05

Frameless TV Market Size, Shares, Growth Analysis, and Forecast 2020-2029Global Frameless TV Market By Type( >40 Inch, 40~50 Inch, 50~60 Inch, 60~70 Inch, >70 Inch ); By Application( Commercial, Residential ); By Region and Key Companies( LG, Panasonic, Samsung, Sceptre, Seiki, Sharp, Sony, TCL, Upstar, Vizio, Hisense, Hair, Philips, Toshiba ):-Industry Segment Outlook Analysis, Market Assessment, Competition Scenario Analysis, Global Trends and Forecast 2020-2029https://techmarketreports.com/report/frameless-tv-market/

Continue reading here:
Coronavirus (COVID-19) Impact on Mucopolysaccharidosis Treatment Market Status, Players, Types, Applications, and Forecast 2020-2029 3w Market News...

Los Angeles, United StatesThe report offers an all-inclusive and accurate research study on the global CRISPR And CRISPR-Associated (Cas) Genes market while chiefly focusing on current and historical market scenarios. Stakeholders, market players, investors, and other market participants can significantly benefit from the thorough market analysis provided in the report. The authors of the report have compiled a detailed study on crucial market dynamics, including growth drivers, restraints, and opportunities. This study will help market participants to get a good understanding of future development of the global CRISPR And CRISPR-Associated (Cas) Genes market. The report also focuses on market taxonomy, regional analysis, opportunity assessment, and vendor analysis to help with comprehensive evaluation of the global CRISPR And CRISPR-Associated (Cas) Genes market.

Key companies operating in the global CRISPR And CRISPR-Associated (Cas) Genes market include : , Caribou Biosciences, Addgene, CRISPR THERAPEUTICS, Merck KGaA, Mirus Bio LLC, Editas Medicine, Takara Bio USA, Thermo Fisher Scientific, Horizon Discovery Group, Intellia Therapeutics, GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1704011/covid-19-impact-on-global-crispr-and-crispr-associated-cas-genes-market

Segment Analysis

The segmental analysis will help companies to focus on high-growth areas of the global CRISPR And CRISPR-Associated (Cas) Genes market. In order to broaden the overall understanding of the global CRISPR And CRISPR-Associated (Cas) Genes industry, the report has segregated the global CRISPR And CRISPR-Associated (Cas) Genes business into varied segments comprising product type, application, and end user. This examination has been carried out based on parameters like size, CAGR, share, production, and consumption. Also, region-wise assessment, wherein lucrative prospects that a region or country is likely to offer has been explored.

Global CRISPR And CRISPR-Associated (Cas) Genes Market Segment By Type:

, Genome Editing, Genetic engineering, gRNA Database/Gene Librar, CRISPR Plasmid, Human Stem Cells, Genetically Modified Organisms/Crops, Cell Line Engineering CRISPR And CRISPR-Associated (Cas) Genes

Global CRISPR And CRISPR-Associated (Cas) Genes Market Segment By Application:

, Genome Editing, Genetic engineering, gRNA Database/Gene Librar, CRISPR Plasmid, Human Stem Cells, Genetically Modified Organisms/Crops, Cell Line Engineering CRISPR And CRISPR-Associated (Cas) Genes

Competitive Landscape:

It is important for every market participant to be familiar with the competitive scenario in the global CRISPR And CRISPR-Associated (Cas) Genes industry. In order to fulfill the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key companies operating in the global CRISPR And CRISPR-Associated (Cas) Genes market include : , Caribou Biosciences, Addgene, CRISPR THERAPEUTICS, Merck KGaA, Mirus Bio LLC, Editas Medicine, Takara Bio USA, Thermo Fisher Scientific, Horizon Discovery Group, Intellia Therapeutics, GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes

Key Questions Answered

Enquire for Customization in this Report: https://www.qyresearch.com/customize-request/form/1704011/covid-19-impact-on-global-crispr-and-crispr-associated-cas-genes-market

Table of Contents

1 Study Coverage1.1 CRISPR And CRISPR-Associated (Cas) Genes Product Introduction1.2 Market Segments1.3 Key CRISPR And CRISPR-Associated (Cas) Genes Manufacturers Covered: Ranking by Revenue1.4 Market by Type1.4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type1.4.2 Genome Editing1.4.3 Genetic engineering1.4.4 gRNA Database/Gene Librar1.4.5 CRISPR Plasmid1.4.6 Human Stem Cells1.4.7 Genetically Modified Organisms/Crops1.4.8 Cell Line Engineering1.5 Market by Application1.5.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size Growth Rate by Application1.5.2 Biotechnology Companies1.5.3 Pharmaceutical Companies1.5.4 Academic Institutes1.5.5 Research and Development Institutes1.6 Coronavirus Disease 2019 (Covid-19): CRISPR And CRISPR-Associated (Cas) Genes Industry Impact1.6.1 How the Covid-19 is Affecting the CRISPR And CRISPR-Associated (Cas) Genes Industry

1.6.1.1 CRISPR And CRISPR-Associated (Cas) Genes Business Impact Assessment Covid-19

1.6.1.2 Supply Chain Challenges

1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products1.6.2 Market Trends and CRISPR And CRISPR-Associated (Cas) Genes Potential Opportunities in the COVID-19 Landscape1.6.3 Measures / Proposal against Covid-19

1.6.3.1 Government Measures to Combat Covid-19 Impact

1.6.3.2 Proposal for CRISPR And CRISPR-Associated (Cas) Genes Players to Combat Covid-19 Impact1.7 Study Objectives1.8 Years Considered 2 Executive Summary2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size Estimates and Forecasts2.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue 2015-20262.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Sales 2015-20262.2 CRISPR And CRISPR-Associated (Cas) Genes Market Size by Region: 2020 Versus 20262.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Retrospective Market Scenario in Sales by Region: 2015-20202.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global CRISPR And CRISPR-Associated (Cas) Genes Competitor Landscape by Players3.1 CRISPR And CRISPR-Associated (Cas) Genes Sales by Manufacturers3.1.1 CRISPR And CRISPR-Associated (Cas) Genes Sales by Manufacturers (2015-2020)3.1.2 CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Manufacturers (2015-2020)3.2 CRISPR And CRISPR-Associated (Cas) Genes Revenue by Manufacturers3.2.1 CRISPR And CRISPR-Associated (Cas) Genes Revenue by Manufacturers (2015-2020)3.2.2 CRISPR And CRISPR-Associated (Cas) Genes Revenue Share by Manufacturers (2015-2020)3.2.3 Global CRISPR And CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR5 and HHI) (2015-2020)3.2.4 Global Top 10 and Top 5 Companies by CRISPR And CRISPR-Associated (Cas) Genes Revenue in 20193.2.5 Global CRISPR And CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.3 CRISPR And CRISPR-Associated (Cas) Genes Price by Manufacturers3.4 CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base Distribution, Product Types3.4.1 CRISPR And CRISPR-Associated (Cas) Genes Manufacturers Manufacturing Base Distribution, Headquarters3.4.2 Manufacturers CRISPR And CRISPR-Associated (Cas) Genes Product Type3.4.3 Date of International Manufacturers Enter into CRISPR And CRISPR-Associated (Cas) Genes Market3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026)4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size by Type (2015-2020)4.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Type (2015-2020)4.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Type (2015-2020)4.1.3 CRISPR And CRISPR-Associated (Cas) Genes Average Selling Price (ASP) by Type (2015-2026)4.2 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size Forecast by Type (2021-2026)4.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Type (2021-2026)4.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Forecast by Type (2021-2026)4.2.3 CRISPR And CRISPR-Associated (Cas) Genes Average Selling Price (ASP) Forecast by Type (2021-2026)4.3 Global CRISPR And CRISPR-Associated (Cas) Genes Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Breakdown Data by Application (2015-2026)5.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size by Application (2015-2020)5.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Application (2015-2020)5.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Application (2015-2020)5.1.3 CRISPR And CRISPR-Associated (Cas) Genes Price by Application (2015-2020)5.2 CRISPR And CRISPR-Associated (Cas) Genes Market Size Forecast by Application (2021-2026)5.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Application (2021-2026)5.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Forecast by Application (2021-2026)5.2.3 Global CRISPR And CRISPR-Associated (Cas) Genes Price Forecast by Application (2021-2026) 6 North America6.1 North America CRISPR And CRISPR-Associated (Cas) Genes by Country6.1.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales by Country6.1.2 North America CRISPR And CRISPR-Associated (Cas) Genes Revenue by Country6.1.3 U.S.6.1.4 Canada6.2 North America CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures by Type6.3 North America CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures by Application 7 Europe7.1 Europe CRISPR And CRISPR-Associated (Cas) Genes by Country7.1.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales by Country7.1.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Revenue by Country7.1.3 Germany7.1.4 France7.1.5 U.K.7.1.6 Italy7.1.7 Russia7.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures by Type7.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures by Application 8 Asia Pacific8.1 Asia Pacific CRISPR And CRISPR-Associated (Cas) Genes by Region8.1.1 Asia Pacific CRISPR And CRISPR-Associated (Cas) Genes Sales by Region8.1.2 Asia Pacific CRISPR And CRISPR-Associated (Cas) Genes Revenue by Region8.1.3 China8.1.4 Japan8.1.5 South Korea8.1.6 India8.1.7 Australia8.1.8 Taiwan8.1.9 Indonesia8.1.10 Thailand8.1.11 Malaysia8.1.12 Philippines8.1.13 Vietnam8.2 Asia Pacific CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures by Type8.3 Asia Pacific CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures by Application 9 Latin America9.1 Latin America CRISPR And CRISPR-Associated (Cas) Genes by Country9.1.1 Latin America CRISPR And CRISPR-Associated (Cas) Genes Sales by Country9.1.2 Latin America CRISPR And CRISPR-Associated (Cas) Genes Revenue by Country9.1.3 Mexico9.1.4 Brazil9.1.5 Argentina9.2 Central & South America CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures by Type9.3 Central & South America CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures by Application 10 Middle East and Africa10.1 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes by Country10.1.1 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Sales by Country10.1.2 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Revenue by Country10.1.3 Turkey10.1.4 Saudi Arabia10.1.5 UAE10.2 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures by Type10.3 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Market Facts & Figures by Application 11 Company Profiles11.1 Caribou Biosciences11.1.1 Caribou Biosciences Corporation Information11.1.2 Caribou Biosciences Description, Business Overview and Total Revenue11.1.3 Caribou Biosciences Sales, Revenue and Gross Margin (2015-2020)11.1.4 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Products Offered11.1.5 Caribou Biosciences Recent Development11.2 Addgene11.2.1 Addgene Corporation Information11.2.2 Addgene Description, Business Overview and Total Revenue11.2.3 Addgene Sales, Revenue and Gross Margin (2015-2020)11.2.4 Addgene CRISPR And CRISPR-Associated (Cas) Genes Products Offered11.2.5 Addgene Recent Development11.3 CRISPR THERAPEUTICS11.3.1 CRISPR THERAPEUTICS Corporation Information11.3.2 CRISPR THERAPEUTICS Description, Business Overview and Total Revenue11.3.3 CRISPR THERAPEUTICS Sales, Revenue and Gross Margin (2015-2020)11.3.4 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Products Offered11.3.5 CRISPR THERAPEUTICS Recent Development11.4 Merck KGaA11.4.1 Merck KGaA Corporation Information11.4.2 Merck KGaA Description, Business Overview and Total Revenue11.4.3 Merck KGaA Sales, Revenue and Gross Margin (2015-2020)11.4.4 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Products Offered11.4.5 Merck KGaA Recent Development11.5 Mirus Bio LLC11.5.1 Mirus Bio LLC Corporation Information11.5.2 Mirus Bio LLC Description, Business Overview and Total Revenue11.5.3 Mirus Bio LLC Sales, Revenue and Gross Margin (2015-2020)11.5.4 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Products Offered11.5.5 Mirus Bio LLC Recent Development11.6 Editas Medicine11.6.1 Editas Medicine Corporation Information11.6.2 Editas Medicine Description, Business Overview and Total Revenue11.6.3 Editas Medicine Sales, Revenue and Gross Margin (2015-2020)11.6.4 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Products Offered11.6.5 Editas Medicine Recent Development11.7 Takara Bio USA11.7.1 Takara Bio USA Corporation Information11.7.2 Takara Bio USA Description, Business Overview and Total Revenue11.7.3 Takara Bio USA Sales, Revenue and Gross Margin (2015-2020)11.7.4 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Products Offered11.7.5 Takara Bio USA Recent Development11.8 Thermo Fisher Scientific11.8.1 Thermo Fisher Scientific Corporation Information11.8.2 Thermo Fisher Scientific Description, Business Overview and Total Revenue11.8.3 Thermo Fisher Scientific Sales, Revenue and Gross Margin (2015-2020)11.8.4 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Products Offered11.8.5 Thermo Fisher Scientific Recent Development11.9 Horizon Discovery Group11.9.1 Horizon Discovery Group Corporation Information11.9.2 Horizon Discovery Group Description, Business Overview and Total Revenue11.9.3 Horizon Discovery Group Sales, Revenue and Gross Margin (2015-2020)11.9.4 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Products Offered11.9.5 Horizon Discovery Group Recent Development11.10 Intellia Therapeutics11.10.1 Intellia Therapeutics Corporation Information11.10.2 Intellia Therapeutics Description, Business Overview and Total Revenue11.10.3 Intellia Therapeutics Sales, Revenue and Gross Margin (2015-2020)11.10.4 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Products Offered11.10.5 Intellia Therapeutics Recent Development11.1 Caribou Biosciences11.1.1 Caribou Biosciences Corporation Information11.1.2 Caribou Biosciences Description, Business Overview and Total Revenue11.1.3 Caribou Biosciences Sales, Revenue and Gross Margin (2015-2020)11.1.4 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Products Offered11.1.5 Caribou Biosciences Recent Development 12 Future Forecast by Regions (Countries) (2021-2026)12.1 CRISPR And CRISPR-Associated (Cas) Genes Market Estimates and Projections by Region12.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast by Regions 2021-202612.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Forecast by Regions 2021-202612.2 North America CRISPR And CRISPR-Associated (Cas) Genes Market Size Forecast (2021-2026)12.2.1 North America: CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast (2021-2026)12.2.2 North America: CRISPR And CRISPR-Associated (Cas) Genes Revenue Forecast (2021-2026)12.2.3 North America: CRISPR And CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2021-2026)12.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Market Size Forecast (2021-2026)12.3.1 Europe: CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast (2021-2026)12.3.2 Europe: CRISPR And CRISPR-Associated (Cas) Genes Revenue Forecast (2021-2026)12.3.3 Europe: CRISPR And CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2021-2026)12.4 Asia Pacific CRISPR And CRISPR-Associated (Cas) Genes Market Size Forecast (2021-2026)12.4.1 Asia Pacific: CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast (2021-2026)12.4.2 Asia Pacific: CRISPR And CRISPR-Associated (Cas) Genes Revenue Forecast (2021-2026)12.4.3 Asia Pacific: CRISPR And CRISPR-Associated (Cas) Genes Market Size Forecast by Region (2021-2026)12.5 Latin America CRISPR And CRISPR-Associated (Cas) Genes Market Size Forecast (2021-2026)12.5.1 Latin America: CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast (2021-2026)12.5.2 Latin America: CRISPR And CRISPR-Associated (Cas) Genes Revenue Forecast (2021-2026)12.5.3 Latin America: CRISPR And CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2021-2026)12.6 Middle East and Africa CRISPR And CRISPR-Associated (Cas) Genes Market Size Forecast (2021-2026)12.6.1 Middle East and Africa: CRISPR And CRISPR-Associated (Cas) Genes Sales Forecast (2021-2026)12.6.2 Middle East and Africa: CRISPR And CRISPR-Associated (Cas) Genes Revenue Forecast (2021-2026)12.6.3 Middle East and Africa: CRISPR And CRISPR-Associated (Cas) Genes Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis13.1 Market Opportunities and Drivers13.2 Market Challenges13.3 Market Risks/Restraints13.4 Porters Five Forces Analysis13.5 Primary Interviews with Key CRISPR And CRISPR-Associated (Cas) Genes Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis14.1 Value Chain Analysis14.2 CRISPR And CRISPR-Associated (Cas) Genes Customers14.3 Sales Channels Analysis14.3.1 Sales Channels14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix16.1 Research Methodology16.1.1 Methodology/Research Approach16.1.2 Data Source16.2 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.

Read more:
CRISPR And CRISPR-Associated (Cas) Genes Market which company is the market leader and how much its sales in 2020 and what it's expected sales for the...

COLUMBIA, Md., May 15, 2020 /PRNewswire/ -- The Foundation Fighting Blindness, the world's leading organization searching for treatments and cures for inherited retinal diseases, has introduced many improvements and upgrades to its My Retina Tracker Registry. Overall, the upgraded platform makes this best-in-class patient database even easier to use for patients, industry, and investigators who access de-identified data for research studies and clinical trial recruitment. Launched in 2013, more than 15,500 IRD patients are active in the Registry. The patient-driven registry is accessible at MyRetinaTracker.org.

"The My Retina Tracker Registry has been an invaluable resource for both IRD patients and research communities. It provides a secure venue for patients to get on the radar screens of therapy developers both industry and researcher partners who are recruiting for clinical trials and conducting studies using human data," says Brian Mansfield, PhD, executive vice president of research and interim chief scientific officer. "From the start, we have been strongly committed to security of privacy coupled with ease-of-use for both patients and professionals. These enhancements are part of our continual process to maximize the registry's usability and efficiently integrate it with our genetic testing programs."

Highlights of upgrades and enhancements:

The Foundation also offers no-cost genetic testing for those affected with IRDs. The Open Access Genetic Testing Program, allows for any eye care professional in the U.S. to order the no-cost test along with a no-cost genetic counseling session for their IRD patients. Neither membership to My Retina Tracker Registry, nor clinician pre-approval, is needed to participate in the Open Access Genetic Testing Program and receive free testing and genetic counseling.

If a person who is tested chooses to join My Retina Tracker Registry, their data is automatically uploaded into their profile from the genetic testing laboratory.

Current sponsors of the new My Retina Tracker Registry include: The George Gund Foundation, Eloxx Pharmaceuticals, Sofia Sees Hope, AGTC and MeiraGTx. Sponsors of the Open Access Genetic Testing Program include: ProQR, Blueprint Genetics, InformedDNA, Sophia Sees Hope, and The George Gund Foundation.

About the Foundation Fighting BlindnessEstablished in 1971, the Foundation Fighting Blindness is the world's leading private funding source for retinal degenerative disease research. The Foundation has raised more than $760 million toward its mission of accelerating research for preventing, treating, and curing blindness caused by the entire spectrum of retinal degenerative diseases including: retinitis pigmentosa, age-related macular degeneration, Usher syndrome, and Stargardt disease. VisitFightingBlindness.orgfor more information.

Media Contact:Chris AdamsVice President, Marketing & Communications[emailprotected]410-423-0585

SOURCE Foundation Fighting Blindness

http://www.FightBlindness.org

Read the original post:
Foundation Fighting Blindness Launches Upgraded My Retina Tracker Registry for People with Inherited Retinal Diseases (IRDs) - PRNewswire

(PRESS RELEASE) CHICAGO In order to help patients with Inherited Retinal Diseases (IRDs) receive an accurate diagnosis through genetic testing, Prevent Blindness, the nations oldest volunteer eye health organization, is embarking on a new awareness initiative to educate the public on IRDs, a group of genetic disorders that can cause severe vision loss or total blindness. A recent editorial noted that IRDs are the leading cause of vision loss in persons between 15 and 45 years of age- impacting one in every 2,000 people.

To continue the Prevent Blindness mission of preventing blindness and saving sight, the group has declared May 17-23, 2020 as Inherited Retinal Disease Genetic Testing Week. As part of this initiative, Prevent Blindness has created a dedicated webpage (to go live on May 15, 2020) with no-cost educational resources on IRDs, providing detailed information on risk factors, therapy and research options, financial assistance services, the importance of genetic testing, and more. Shareable social media graphics on IRDs are also available. Development of these new resources was supported by a donation from Spark Therapeutics, a gene therapy company striving to challenge the inevitability of genetic disease.

The most common types of IRDs include:

All those diagnosed with IRDs should work with their healthcare professional to develop a disease management plan tailored to the patients needs.

Patients with suspected IRDs are encouraged to participate in genetic testing, even those who were tested more than five years ago and did not receive a definitive result. According to the National Institutes of Health, genetic testing is a type of medical test that identifies changes in chromosomes, genes, or proteins. The results of a genetic test may provide a detailed diagnosis which confirms or rules out most suspected genetic conditions and the test can help determine a persons chance of developing or passing on a genetic disorder to their children. Free genetic testing is now available from select organizations and commercial businesses, including through the ID YOUR IRD program.

Inherited retinal diseases can have a significant impact on the quality of life for patients, including affecting the ability to work and live independently, said Jeff Todd, president and CEO of Prevent Blindness. Fortunately, today there are more therapies being researched than ever before. We encourage patients and their caregivers to educate themselves on steps that can be taken today to save sight for tomorrow.

As a leading gene therapy company with a strong commitment to genetic testing for the IRD community, Spark Therapeutics is pleased to support the Prevent Blindness inaugural IRD Genetic Testing Week, said Dan Chung, DO, MA, ophthalmology therapeutic area leader, Spark Therapeutics. We encourage patients living with IRDs and caregivers to pursue genetic testing in order to receive a true, genetic diagnosis.

For more information on IRDs and genetic testing for vision issues, please call Prevent Blindness at (800) 331-2020 or visit here. For a listing of vision care financial assistance programs in English or Spanish, visit here.

Read more here:
Prevent Blindness Offers New Educational Resources on IRD's, Importance of Genetic Testing and Services - InvisionMag

Legends of Tomorrow season 5, episode 11, "Ship Broken" affirmed Sara Lance's superpower and the price she had to pay to take advantage of it.

Warning: SPOILERS for Legends of Tomorrow, Season 5, Episode 11, "Ship Broken."

Legends of Tomorrowseason 5, episode 11, "Ship Broken" confirmed that Sara Lance had developed the power to see the future, but revealed that she had also lost her sight. Interestingly enough, this places Sara within two categories of hero common to both superhero comics and mythology in general; the blind seer and the blind warrior.

The youngest daughter of Quentin and Dinah Lance, Sara Lance is perhaps the most popular of the original characters created for the Arrowverse. Whereas Oliver Queen spent "five years in Hell" learning the skills he would later use to save his city, Sara Lance spent six years struggling to survive as a captive of the mad scientist Anthony Ivo and training as an assassin under the tutelage of Ra's Al Ghul. She was later given the rare opportunity to leave the League of Assassins, returning home to become a protector of the innocent as Canary. Following her death and resurrection, she took on the alias White Canary and became one of the founding members of the Legends of Tomorrow, eventually becoming the Captain of the Waverider when Rip Hunter left the team.

Related: Legends of Tomorrow Reveals How Heatwave Funds The Arrowverse Team

Throughout all of this, Sara has held her own against metahumans and magicians alike, despite lacking any superpowers of her own. That changed in the Legends of Tomorrow episode "The Great British Fake Off," where Sara seemed to start seeing events play out just before they happened. This occurred twice before Sara lapsed into a coma. She woke up early on in the following episode, "Ship Broken," but quickly realized that she had been struck blind - an unfortunate consequence for being able to see the future.

Sara's precognition took on a new form in this episode, giving her horrific visions of her teammates's deaths whenever she touched anyone's hand, ala Johnny Smith in The Dead Zone. By the end of the episode, Sara had learned how to focus this ability, shifting her perspective to check on specific people while holding another person's hand. Through this, she was able to witness and then avert Mick Rory's death by hellhound while holding hands with John Constantine.

It's worth noting that the loss of her sight has not robbed Sara Lance of her ability to fight. When Sara protested Constantine's statement that he was glad he had her to protect him while facing the hellhound, he reminded her that she was blind, not deaf. Trained to fight while blindfolded, Sara was able to backflip over a prone Constantine and deliver an impressive midair kick to the hellhound as it tried to pounce on her.While she may not be on par with Daredevil just yet, Sara more than proved her worthiness to continue leading the Legends of Tomorrow.

More: Why Legends of Tomorrow Keeps Recruiting Its Villains To The Team

The Flash Theory: Barry Was Replaced In The Season 6 Finale

Matt Morrison has been writing about comics since before the word"blogging" was coined. He got his start writing for thelegendary DC Comics digital fanzine Fanzing,before receiving his own column, The Mount. Since then he has gone onto write for over a dozen websites, including 411Mania, ComicsNexus and The Cult of Nobody. He holds both an MS in InformationScience from the University of North Texas and a BFA from theUniversity of Texas at Arlington. Known as a font of comic bookhistory trivia, he has delivered lectures on the history of AmericanComic Books, Japanese Manga and Cosplay at over a dozen conventionsand served as an Expert In-Residence for a course on Graphic Novelsfor Librarians at the University of North Texas. In addition to hiswork for Screen Rant, Matt is currently the Managing Editor ofKabooooom.com, the housecritic of Explore The Multiverse and writes reviews for NoFlying, No Tights a graphic literature and anime review siteaimed at teachers and librarians. He also maintains a personal blog My Geeky Geeky Ways which hosts his extensive episode guide for the television seriesmaking up The Arrowverse as well as hiscomedic Lets Play videos. What little spare time he has isdevoted towards acting, role-playing, movie-riffing and sarcasm. Youcan follow his adventures on Twitter, @GeekyGeekyWays.

See original here:
Legends of Tomorrow: Saras Blindness & Superpower Explained - What It Means - Screen Rant

NewsEnvironmentThe Canal and River Trust spends nearly 100,000 a year trying to control giant hogweed and Japanese knotweed

Wednesday, 13th May 2020, 9:20 am

After being introduced into Britain in the early 19th century from central Asia as an ornamental plant, it began growing along canals and rivers. However, in recent years it has appeared in streets and gardens, causing experts to worry that because its pretty and looks like cow parsley, or common hogweed, children may mistake it for something harmless.

If the sap gets rubbed into the eyes it can cause blindness. After contact with the plant, the burns can last for several months and the skin can remain sensitive to light for many years, and the NHS says anyone who touches giant hogweed should wash the affected area with soap and water, and keep it covered.

Growing out of control

Guy Barter, chief horticulturist at the Royal Horticultural Society, said that flooding this year may have carried seeds to new areas, where warm weather has helped the plants grow to at least 2 metres tall, and sometimes up to 5 metres.

Most people know about foxglove and deadly nightshade, he says. But not as many know about giant hogweed. Co-ordinated action is the only way to get rid of it. In the 1990s there was very little of it. The proliferation has got worse everyyear.

The Canal and River Trust spends nearly 100,000 a year trying to control giant hogweed and Japanese knotweed. Plant tracker the Environment Agencys database of invasive, non-native plants reports hundreds of sightings across all of the UK, from Inverness to Kent.

Agonising burns

Dean Simmons was left with agonising body burns in 2015 after brushing against the weed in Taunton, Somerset. I was out fishing and didnt see it until it was too late, he told the BBC at the time, and a day later I was on morphine.

There have since been reports of adults and children hospitalised with third-degree burns.

So, how to spot it? Giant hogweed has large leaves, spotted leaf stalks and a hollow, reddish-purple stem with fine spines that make it appear furry.

Giant hogweed is one of several UK plants to steer clear of. As well as deadly nightshade and the spiky pink and purple foxglove, poison hemlock can also be fatal if ingested. The yellow-and-green plant lords and ladies also has severely poisonous berries but if put on the tongue, they leave an acrid taste as a warning.

Original post:
What is giant hogweed? How to identify the invasive and toxic plant which can cause burns and even blindness - inews

Giant Hogweed (Heracleum mantegazzianum) is a large plant, but although grand and showy in its appearance, it is an invasive plant that you dont want to touch. Also in the same family,Apiaceae the carrot family, is wild parsnip (Pastinaca sativa), another invasive species to avoid. Both plants contain chemicals that can cause a toxic skin reaction when humans encounter the plants sap.

Furanocoumarins, when combined with sunlight, can cause phytophotodermatitis, a serious skin inflammation. The chemical prevents the skin from protecting itself against sunlight, which can lead to a severe sunburn. The reaction can be as mild as skin discoloration or as severe as large, painful blisters. The effects of giant hogweed can be much worse than that of wild parsnip, with some blisters similar to third-degree burns, permanent scarring, discoloration of the skin, increased sensitivity to sunlight that may last for years, and contact with the eyes could lead to blindness.

Giant hogweed was introduced to the United States in the early 1900s. as an ornamental. One of the first plantings was in gardens near Highland Park in Rochester. It escaped cultivation and has now become established in the Northeast and parts of Canada.

Characteristics:

White flowers clustered into an umbrella-shaped flower cluster, up to 2.5 feet across, blooms between June and July (note: plant generally produces a flowering stalk in 3 to 5 years but can take up to 8 years or more)

Between 7 to 14 feet tallwith huge leaves, incised and deeply lobed, up to 5 feet across

Stems are green with purple splotches and coarse white hairs, 2-4 inches in diameter

Seeds are dry, flattened, oval and approximately 3/8-inch-long and tan with brown lines

Except for its towering size, giant hogweed can easily be mistaken for other umbrel plants.

If you see Giant Hogweed, keep your distance, and take high-resolution photos of the entire plant, stem, leaves, flowers and/or seeds. Photos and detailed directions to the infestation can be emailed to DEC at ghogweed@dec.ny.gov or contact your local Cornell Cooperative Extension office for assistance with identification.

DEC crews visit each confirmed infestation site of giant hogweed and use an appropriate control method for the size of infestation and location. This service is free of charge to the landowner. Sites are visited each year until the plants are eradicated. For sites to be monitored and controlled, the landowner must give annual permission.

Wild Parsnip is native to southern and central Europe and was possibly brought to North America as a root crop by colonists as early as the 1600s. It has become established throughout the northern United States and southern Canada.

Characteristics:

Yellow flowers clustered into an umbrella-shaped flower cluster, 4-6 inches wide, blooms between May to mid-July (note: flowering usually occurs during the second year of growth)

Between 2 to 5 feet tall with yellowish-green leaves with 5 to 15 toothed and variably lobed leaflets

Stems are yellowish-green with vertical grooves

Seeds are flat, brown, and slightly winged

Both plants can be found growing on roadsides, fields, pastures, along trails, any place where the soil has been disturbed, and along streams and rivers.

If you see Wild Parsnip, manual removal of plants can be effective for new infestations and small areas. When removing plants, wear gloves, long-sleeved shirts, pants, boots, and eye protection to prevent contact with the sap. Synthetic, water-resistant materials are recommended. Before the plant going to seed, cut the root 1-2 inches below the soil or pull by hand. If removing the plants after they have gone to seed, cut off the seed head and place it in a plastic bag. Leave the bags in the sunlight for one week to kill the seeds before disposal. Mowing only after it has flowered, but before it goes to seed, can kill the plant. When mowing, take precautions to prevent sap from contacting skin and eyes. Clean all protective clothing, gear, tools, and equipment thoroughly. Herbicides such as glyphosate or triclopyr can be applied as spot treatments; follow product labels carefully. Monitor the area long-term for seedlings emerging from the seed bank.

What to do if you come in contact with these plants?Immediately wash the area with soap and COLD water and keep the area away from sunlight for 48 hours. If a reaction occurs, see a physician.

The rest is here:
Giant Hogweed and Wild Parsnip: Do Not Touch! - Steuben Courier

Fifteen years have elapsed since the worst bout of bloodletting that Uzbekistan has seen in its post-independence history, but still the authorities, even under the rule of self-styled reformer President Shavkat Mirziyoyev, appear uninterested in pursuing a thorough and transparent investigation.

The uprising in the ancient Ferghana Valley bazaar city of Andijan which began on May 13, 2005, came on the heels of a wave of arrests of local businessmen tied to another one by their strong Islamic faith.

The thousands that took their positions on the citys Bobur Square were almost all unarmed citizens, although they also included some gunmen who had been sprung overnight from the local prison. After days of tension, then President Islam Karimovs government sent in heavily armed troops, who indiscriminately opened fire on the crowd.

There is no consensus on the exact number of fatalities as the authorities swiftly squelched any pleas to conduct an independent investigation. The official figure is 187 dead. Rights activists believe the real figure is many times greater.

Although the current political elite in Tashkent does not openly talk about this, the disastrous economic situation and political consequences brought on by the Andijan massacre and its aftermath in large part contributed to President Mirziyoyevs determination to break with the Karimov legacy and begin certain reforms, said Steve Swerdlow, a human rights lawyer and Central Asia expert.

There was a slight shift in the official tone earlier this year when Deputy Prosecutor General Svetlana Artykovagave an interviewto a local outlet,Qalampir.uz, in which she appeared to concede that excessive force was deployed. The remarks made by Artykova, who was the spokeswoman for the prosecutors office in May 2005, could only have been made with approval from above.

When asked if weapons were used by government forces against civilians, Artykova answered that there had been no clear coordination between troops and the national leadership and that this was why a certain number of citizens died during the rally.

Some officials found responsible for unlawful killing were convicted and some were already out of prison, Artykova claimed. This was the first time any Uzbek official has alleged that any officials were imprisoned for their involvement in the Andijan events.

The idea that government troops would have acted with such force upon their own initiative defies credibility, however.

Indeed, documentaries produced for state television since Mirziyoyev came to power have sought to whitewash the actions of senior security officials, including then Interior MinisterZokir Almatov.After the Andijan events, Almatov was included on a list of Uzbek officials sanctioned by the European Union and the United States. Under international pressure, Karimov finally caved and dismissed Almatov.

But Almatov has since beenrehabilitatedand beendraftedby Mirziyoyev to assist in reforming the police force.

In the wake of Andijan, the repression of devout Muslims, whose presence was especially pronounced in the Ferghana Valley, only escalated. Many rights activists were also hounded out of Uzbekistan. Numerous international organizations were forced to shutter.

Although there have been many improvements in those areas, Kamoliddin Rabimov, a political migr residing in France, believes the Mirziyoyev administration is unlikely to wish to revisit what happened in May 2005.

For the political elite, especially for the security forces, any such step would be considered a source of destabilization. And for the public, the issue of the Andijan tragedy has been, and remains to be, a very sensitive, painful matter, Rabimov said.

Ravshan Nazarov, a historian in Tashkent, told Eurasianet that there continues to be a split in perceptions about what actually happened in Andijan. Many hold the opinion that the uprising was the entirely the work of extremists and terrorists a view that has been eagerly promoted by state-funded action movies, at least one of which is shown as in-trip entertainment on trains running between Tashkent and Andijan. Another camp recalls the events as just another instance of cruel suppression of a peaceful demonstration.

It is this polarized set of perceptions that makes a proper study of the uprising so necessary, said Nazarov

A serious and thorough analysis of all available materials and documents on the events of 2005 remains to be done. It is necessary to talk directly with participants and witnesses of those events, he told Eurasianet.

Such a process would in any event only be in keeping with Uzbekistans pledges to bodies like theUN Human Rights Committee and Committee Against Torture to enable an impartial and international investigation.

There is more at stake than just fresh insight into a specific set of events.

Truth-telling and public discussion about the Andijan massacre are deeply important 15 years after the events, said Swerdlow. Andijan in many ways was the defining event of the Karimov era. It is necessary to comprehend and study it in an open format for national healing. Understanding the painful history of Andijan will ultimately help Uzbekistan make a transition to a more open and democratic society.

Excerpt from:
Uzbekistan: Andijan blindness slows transition to era of openness, experts say - Eurasianet

When the seas of life get rough, some readers look for escape, while others dive right in. So it is during the pandemic, when many book lovers are turning toward apocalyptic fiction.

A modern classic of the genre is Emily St. John Mandels Station Eleven, which tells the story of a nomadic group of entertainers in the years after a flu has destroyed civilization. I would not recommend reading Station Eleven in the middle of a pandemic, Mandel told the L.A. Times in an interview.

Yet many people are doing just that: The book is selling briskly just as Mandels new novel of financial disaster, The Glass Hotel, settles into the Los Angeles Times bestseller list. Mandel joins the L.A. Times Book Club on May 19 for a virtual discussion of these two eerily timely novels.

In advance of Mandels appearance, we asked her and a few other authors to help us put together an end-of-world reading list.

Mandel called the 1961 Hugo Award winner an interesting and somewhat haunting story. It was the first post-apocalyptic book I read, and reading it made me think for the first time about what a post-apocalyptic world might look like.

Susan Orlean, author of The Library Book, suggested the classic dystopian novel, which played a role in her nonfiction bestseller about the 1986 fire that closed the Los Angeles Central Library for seven years. Orlean also mentioned A Canticle for Leibowitz.

T.C Boyle, author of the upcoming Talk to Me, called Fiskadoro a poetic fever dream which takes place in the Florida Keys a generation after a nuclear war has destroyed most of civilization and rendered vast territories uninhabitable. The novel opens up the reader to what culture is, what it means to its constituency, and how it draws from the traditions of the past in order to create a rationale for the present.

Marlon James, winner of the 2020 L.A. Times Ray Bradbury Prize, described the Frankenstein authors later work as the original speculative novel. Funny enough, it was a plague I was like, Damn, girl. The original dystopian novel got it right! He also mentioned The Handmaids Tale, by Margaret Atwood.

The vivid, unusual, stirring characters make it a piquant and often enjoyable read despite the pointed bleakness of the setting, Malka Older, author of Infomocracy, said of Solomons debut science fiction novel. Its structurally and thematically daring and manages to include a little bit of hope while leveling a devastating critique at racism and fascism.

Lessings writing is so perfect and full of beautiful details that her apocalypse feels inextricably linked to the rest of her narrative, said Charlie Jane Anders, author of The City in the Middle of the Night. I feel like people dont read Lessing as much as they did maybe 20 years ago, and this makes me incredibly sad of all the 20th century lit authors, shes the one whose work is the most relevant and timeless in 2020. Anders also recommended Cats Cradle, by Kurt Vonnegut, The Fifth Season, by N. K. Jemisin and Jos Saramagos Blindness.

Wil Wheaton, actor and author of Just a Geek, suggested this three-book anthology edited by John Joseph Adams and Hugh Howey. The collection tells stories from three distinct periods in the apocalypse: The end is nigh, the end is now, and the end has come. While there are fantastic stand-alone stories in each volume, for a reader who wants to take the whole ride, there are some extremely rewarding tales. Standouts include Charlie Jane Anders, Scott Sigler and Seanan McGuire.

Aimee Liu, author of the new novel Glorious Boy, cited the Pulitzer Prize-winning tales unflinching humanity in the face of horror and uncertainty, all amplified by McCarthys refusal to name the precise cause, date, or nature of Earths collapse. Liu also mentioned The Book of Aron, by Jim Shepard.

Im a Shakespeare buff, and I thought it was terribly inventive, said Jess Walter, author of Beautiful Ruins and the upcoming Cold Millions. I admired her deft writing touch and the way she moved back and forth in time. Walter also mentioned Oryx and Crake, by Margaret Atwood, and Cats Cradle, by Kurt Vonnegut.

Alex Espinoza, author of Cruising, is another fan of Saramagos story of an epidemic of blindness that sweeps through an unidentified city. The novel focuses on a group of strangers who are among the first to get infected and are quarantined in a filthy, crowded asylum where they must band together in order to survive. A terrifying and timely story.

Wolk has been a senior correspondent for Reuters and NBC News, among other publications.If you go: Book ClubEmily St. John Mandel, author of Station Eleven and The Glass Hotel, joins the L.A. Times Book Club in conversation with reporter Carolina A. Miranda.

When: 7 p.m. May 19

Where: Free virtual event livestreaming on the Los Angeles Times Facebook Page and YouTube.

More info: latimes.com/bookclub

View original post here:
Quarantine books: Your essential end-of-the-world reading list - Los Angeles Times

Seva Foundation will celebrate 1960s counter-culture icon Wavy Gravys 84th birthday with a Quarantine Concert featuring previously unreleased archival videos from past Seva benefit concerts spanning 2007 to 2019. Bob Weir, David Crosby & Graham Nash, Bonnie Raitt & Ruthie Foster, Hot Tuna, Zero and many more musicians will be part of the online event.

Other acts that are part of Sevas Quarantine Concert include Ani DiFranco, Blind Boys Of Alabama, Chris Robinson, Dr. John & Buffy Sainte-Marie, Jackson Browne, Jason Mraz, New Riders Of The Purple Sage, Poor Mans Whiskey, Roy Rogers & Carlos Reyes, Steve Kimock, Rising Appalacia and Steve Earle. The event will be able to be streamed between May 14 and 17. Follow this link for more information.

The Berkeley, California-based Seva Foundation is a global nonprofit eye care organization that transforms lives and strengthens communities by restoring sight and preventing blindness preventing and treating blindness and other visual impairments. The Grateful Dead performed at the first Seva benefit concert in 1979.

Read the original here:
Seva Foundation Celebrating Wavy Gravy's 84th Birthday With Archival Video Release - JamBase